These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pathogens use carbohydrates to escape immunity induced by dendritic cells. van Kooyk Y; Engering A; Lekkerkerker AN; Ludwig IS; Geijtenbeek TB Curr Opin Immunol; 2004 Aug; 16(4):488-93. PubMed ID: 15245744 [TBL] [Abstract][Full Text] [Related]
11. An evolutionary perspective on C-type lectins in infection and immunity. van den Berg LM; Gringhuis SI; Geijtenbeek TB Ann N Y Acad Sci; 2012 Apr; 1253():149-58. PubMed ID: 22288724 [TBL] [Abstract][Full Text] [Related]
12. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Dam TK; Brewer CF Glycobiology; 2010 Mar; 20(3):270-9. PubMed ID: 19939826 [TBL] [Abstract][Full Text] [Related]
13. Integration of lectin-glycan recognition systems and immune cell networks in CNS inflammation. Mendez-Huergo SP; Maller SM; Farez MF; Mariño K; Correale J; Rabinovich GA Cytokine Growth Factor Rev; 2014 Jun; 25(3):247-55. PubMed ID: 24684768 [TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni worm glycolipids induce an inflammatory phenotype in human dendritic cells by cooperation of TLR4 and DC-SIGN. van Stijn CM; Meyer S; van den Broek M; Bruijns SC; van Kooyk Y; Geyer R; van Die I Mol Immunol; 2010 Apr; 47(7-8):1544-52. PubMed ID: 20170964 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Joffre O; Nolte MA; Spörri R; Reis e Sousa C Immunol Rev; 2009 Jan; 227(1):234-47. PubMed ID: 19120488 [TBL] [Abstract][Full Text] [Related]
16. Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: an emerging role of protein-glycan interactions. Ilarregui JM; Rabinovich GA Neuroimmunomodulation; 2010; 17(3):157-60. PubMed ID: 20134191 [TBL] [Abstract][Full Text] [Related]
17. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Rabinovich GA; Croci DO Immunity; 2012 Mar; 36(3):322-35. PubMed ID: 22444630 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells from bench to bedside and back. Adema GJ Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337 [TBL] [Abstract][Full Text] [Related]
19. Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Jenner J; Kerst G; Handgretinger R; Müller I Exp Hematol; 2006 Sep; 34(9):1212-8. PubMed ID: 16939814 [TBL] [Abstract][Full Text] [Related]
20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]